We measured fingernail metal levels, Békésy-type pure-tone thresholds and distortion product otoacoustic emission (DPOAE) levels in 59 subjects residing in the gold mining community of Bonanza, Nicaragua. Auditory testing revealed widespread hearing loss in the cohort. Nail metal concentrations (mercury, lead, aluminum, manganese and arsenic) far exceeded reference levels. No relationship was found between metal levels and auditory test results for the group as a whole. Statistically significant relationships were found between DPOAE response amplitudes and metal concentrations in a subgroup with less than 40 h per week of significant noise exposure; however, conclusions regarding these relationships should be tempered by the large number of analyses performed. Several young individuals with high metal levels reported neurological symptoms and had poor hearing. The data suggest that metal levels in artisanal mining communities present a significant public health problem and may affect hearing.

Keywords:
Ototoxicity, Mercury, Lead, Arsenic, Manganese, Aluminum, Distortion product otoacoustic emission
1.
Aly S, Mousa S, El-Kahky M, et al: Toxic deafness. 1. Histological study of the effect of arsenic, salicylates and quinine on the organ of Corti of guinea pigs. J Egypt Med Assoc 1975;58:144–157.
2.
Amin-Zaki L, Majeed MA, Clarkson TW, Greenwood MR: Methylmercury poisoning in Iraqi children: clinical observations over two years. Br Med J 1978;1:613–616.
3.
Anniko M: Damage to Reissner’s membrane in the guinea-pig cochlea following acute atoxyl intoxication. Acta Otolaryngol 1976;81:415–423.
4.
Anniko M, Sarkady L: Cochlear pathology following exposure to mercury. Acta Otolaryngol 1978;85:213–224.
5.
Basu N, Nam DH, Kwansaa-Ansah E, Renne EP, Nriagu JO: Multiple metals exposure in a small-scale artisanal gold mining community. Environ Res 2011;111:463–467.
6.
Bencko V, Symon K: Test of environmental exposure to arsenic and hearing changes in exposed children. Environ Health Perspect 1977;19:95–101.
7.
Buchanan LH, Counter SA, Ortega F: Environmental lead exposure and otoacoustic emissions in andean children. J Toxicol Environ Health A 2011;74:1280–1293.
8.
Cary R, Clarke S, Delic J: Effects of combined exposure to noise and toxic substances – Critical review of the literature. Ann Occup Hyg 1997;41:455–465.
9.
Chu PL, Wu CC, Hsu CJ, Wang YT, Wu KD: Potential ototoxicity of aluminum in hemodialysis patients. Laryngoscope 2007;117:137–141.
10.
Chuang HY, et al: A case-control study on the relationship of hearing function and blood concentrations of lead, manganese, arsenic, and selenium. Sci Total Environ 2007;387:79–85.
11.
Corbett CE, et al: Health evaluation of gold miners living in a mercury-contaminated village in Serra Pelada, Para, Brazil. Arch Environ Occup Health 2007;62:121–128.
12.
Counter SA: Neuro-ototoxicity in andean adults with chronic lead and noise exposure. J Occup Environ Med 2002;44:30–38.
13.
Counter SA: Neurophysiological anomalies in brainstem responses of mercury-exposed children of Andean gold miners. J Occup Environ Med 2003;45:87–95.
14.
Counter SA, Buchanan LH: Neuro-ototoxicity in Andean adults with chronic lead and noise exposure. J Occup Environ Med 2002;44:30–38.
15.
Counter SA, Buchanan LH, Laurell G, Ortega F: Blood mercury and auditory neuro-sensory responses in children and adults in the Nambija gold mining area of Ecuador. Neurotoxicology 1998;19:185–196.
16.
Ding D, Roth J, Salvi R: Manganese is toxic to spiral ganglion neurons and hair cells in vitro. Neurotoxicology 2011;32:233–241.
17.
Eisler R: Health risks of gold miners: a synoptic review. Environ Geochem Health 2003;25:325–345.
18.
Fausti SA, Wilmington DJ, Helt PV, Helt WJ, Konrad-Martin D: Hearing health and care: the need for improved hearing loss prevention and hearing conservation practices. J Rehabil Res Dev 2005;42:45–62.
19.
Forst LS, Freels S, Persky V: Occupational lead exposure and hearing loss. J Occup Environ Med 1997;39:658–660.
20.
Garland M, et al: Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493–497.
21.
Gorga MP, Stephen TN, Tiffany AJ, Darcia MD, Cassie AG: Distortion-product otoacoustic emissions in relation to hearing loss; in Glattke TJ, Robinette MS (eds): Otoacoustic Emissions: Clinical Applications. New York, Thieme Medical Publishers, 2007, pp 197–226.
22.
Goulle JP, et al: Application of inductively coupled plasma mass spectrometry multi-element analysis in fingernail and toenail as a biomarker of metal exposure. J Anal Toxicol 2009;33:92–98.
23.
Guo JX, Hu L, Yand PZ, et al: Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007;42:1853–1858.
24.
Hornsby B, Kelly T, Hall JW: Normative data for five FDA-approved distortion product OAE systems. Hear J 1996;49:39–46.
25.
Hursh JB, Clarkson TW, Miles EF, Goldsmith LA: Percutaneous absorption of mercury vapor by man. Arch Environ Health 1989;44:120–127.
26.
Hwang YH, Chiang HY, Yen-Jean MC, Wang JD: The association between low levels of lead in blood and occupational noise-induced hearing loss in steel workers. Sci Total Environ 2009;408:43–49.
27.
Johnson TA: Cochlear sources and otoacoustic emissions. J Am Acad Audiol 2010;21:176–186.
28.
Kurland LT, Faro SN, Siedler H: Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol 1960;1:370–395.
29.
Lasky RE, Maier MM, Snodgrass EB, Hecox KE, Laughlin NK: The effects of lead on otoacoustic emissions and auditory evoked potentials in monkeys. Neurotoxicol Teratol 1995;17:633–644.
30.
Liang GH, Jarlebark L, Ulfendahl M, Moore EJ: Mercury (Hg2+) suppression of potassium currents of outer hair cells. Neurotoxicol Teratol 2003;25:349–359.
31.
Mizukoshi K, et al: Neurotological follow-up studies upon Minamata disease. Acta Otolaryngol Suppl 1989;468:353–357.
32.
Morata TC: Chemical exposure as a risk factor for hearing loss. J Occup Environ Med 2003;45:676–682.
33.
Morata T: Promoting hearing health and the combined risk of noise-induced hearing loss and ototoxicity. Audiol Med 2007;5:33–40.
34.
Morton J, Mason HJ, Ritchie KA, White M: Comparison of hair, nails and urine for biological monitoring of low level inorganic mercury exposure in dental workers. Biomarkers 2004;9:47–55.
35.
Musiek FE, Hanlon DP: Neuroaudiological effects in a case of fatal dimethylmercury poisoning. Ear Hear 1999;20:271–275.
36.
Nikolov Z: Hearing reduction caused by manganese and noise. Otorhinolaryngol Audiophonol Chir Maxillofac 1974;23:231–234.
37.
Osman K, et al: Lead exposure and hearing effects in children in Katowice, Poland. Environ Res 1999;80:1–8.
38.
Rice DC: Effects of lifetime lead exposure in monkeys on detection of pure tones. Fundam Appl Toxicol 1997;36:112–118.
39.
Ritchie KA, et al: Health and neuropsychological functioning of dentists exposed to mercury. Occup Environ Med 2002;59:287–293.
40.
Rothwell JA, Boyd PJ: Amalgam dental fillings and hearing loss. Int J Audiol 2008;47:770–776.
41.
Rybak LP: Hearing: the effects of chemicals. Otolaryngol Head Neck Surg 1992;106:677–686.
42.
Saunders JE, et al: Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope 2007;117:387–398.
43.
Veiga MM, Maxson PA, Hylander LD: Origin and consumption of mercury in small-scale gold mining. J Clean Prod 2006;14:436–447.
44.
Wassick KH, Yonovitz A: Methyl mercury ototoxicity in mice determined by auditory brainstem responses. Acta Otolaryngol 1985;99:35–45.
45.
Wickre JB, Folt CL, Sturup S, Karagas MR: Environmental exposure and fingernail analysis of arsenic and mercury in children and adults in a Nicaraguan gold mining community. Arch Environ Health 2004;59:400–409.
46.
Wu TN, et al: Effects of lead and noise exposures on hearing ability. Arch Environ Health 2000;55:109–114.
47.
Yoshizawa K, et al: Mercury and the risk of coronary heart disease in men. N Engl J Med 2002;347:1755–1760.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.